April 2016


Webinar on Personalized Medicine and Alzheimer’s Disease Now Available

On February, 29, 2016, ACT-AD presented a webinar on personalized medicine and Alzheimer’s disease with experts Jason H. Karlawish, M.D., J. Michael Ryan, M.D., and Cara Tenenbaum, J.D.  ACT-AD has now made an archived version of the webinar available as well as other approved materials from the event. You can find all of the information about the webinar here. We want to once again thank all of our experts who participated, and we look forward to future webinars.

Save the Date for ACT-AD’s Ninth Annual FDA/AD Allies Meeting/November 16

Mark your calendars! ACT-AD’s Ninth Annual FDA/AD Allies Meeting is set for Wednesday, November 16, 2016, at the Bethesda North Marriott Hotel and Conference Center (5701 Marinelli Road, North Bethesda, Maryland, 20852). We’ll be posting additional information over the next few months, so be sure to check for updates in our upcoming newsletters. You can also send an email to Cynthia Bens.

Researchers Explore Role of Microglia in Alzheimer’s Disease

Experts are looking into how microglia plays a part in the development of conditions such as Alzheimer’s disease and schizophrenia. A study published in the journal Science offers findings that “suggest that the complement-dependent pathway and microglia that prune excess synapses in development are inappropriately activated and mediate synapse loss in AD.”  You can also learn more about the study here.

LEAD Coalition Looking for Communications & Advocacy Director

Our friends at the Leaders Engaged on Alzheimer’s Disease (the LEAD Coalition) are looking for a communications and advocacy director to promote its outreach efforts through mobilizing grassroots advocacy by stakeholder organizations through media and policy initiatives. For additional information, go here.

ICYMI: PBS Special Focuses on Alzheimer’s Disease

On April 13, PBS debuted a special called Can Alzheimer’s Be Stopped? The program took an in-depth look at the disease and offered the impressions of the experts who are looking for a cure. It also looked into the lives of those who affected are by AD and the importance of clinical trials. To learn more, go here.